If generative AI could contribute in the slightest to such discoveries—as has been promised since the start of the AI boom—where would the technology ... company pioneering AI-driven drug ...

Nvidia said that it has partnered with companies ... to improve drug discovery and genomics research. Companies including Illumina (ILMN) and IQVIA (IQV) are currently using Nvidia technology.

It all started at Oxford University, when LumiSTAR co-founders Yu-Fen Chang, CEO, and Min-Wen Chung, COO, were working on the development of a novel bioimaging technology for drug screening and ...